Koninklijke DSM NV
AEX:DSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cholamandalam Investment and Finance Company Ltd
NSE:CHOLAFIN
|
IN |
|
D
|
Dalian Huarui Heavy Industry Group Co Ltd
SZSE:002204
|
CN |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
Urovo Technology Co Ltd
SZSE:300531
|
CN |
|
Profit Cultural and Creative Group Co Ltd
SZSE:300640
|
CN |
|
Vizio Holding Corp
NYSE:VZIO
|
US |
Koninklijke DSM NV
Capital Expenditures
Koninklijke DSM NV
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Koninklijke DSM NV
AEX:DSM
|
Capital Expenditures
-€651m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Corbion NV
AEX:CRBN
|
Capital Expenditures
-€68.2m
|
CAGR 3-Years
34%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Akzo Nobel NV
AEX:AKZA
|
Capital Expenditures
-€309m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
Koninklijke DSM NV
Glance View
Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. The company is headquartered in Heerlen, Limburg and currently employs 21,358 full-time employees. The firm's segments include Nutrition, Materials, Innovation Center and Corporate Activities. Its Nutrition segment focuses on human nutrition & health, food & beverages, personal care and aroma ingredients and animal nutrition & health. Its Materials segment engages in specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. Its Innovation Center segment focuses on innovation and the growth of DSM’s existing core business through adjacent technologies via its Corporate Research Program, as well as through the Company’s venturing and licensing activities. Its Corporate Activities segment comprises operating and service activities.
See Also
What is Koninklijke DSM NV's Capital Expenditures?
Capital Expenditures
-651m
EUR
Based on the financial report for Dec 31, 2022, Koninklijke DSM NV's Capital Expenditures amounts to -651m EUR.
What is Koninklijke DSM NV's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-3%
Over the last year, the Capital Expenditures growth was -13%. The average annual Capital Expenditures growth rates for Koninklijke DSM NV have been -1% over the past three years , -3% over the past five years .
